Delivery Order SPE2DB20D2014-SPE2DB25FC56R
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,200.00 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance completed by August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,167.80 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,173.54 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitively awarded, firm fixed-price contract was executed on August 4, 2025, with a completion date of August 5, 2025, and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,434.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This non-set-aside delivery order was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.56 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and utilized firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract vehicle, reflecting the company's...
- The Defense Logistics Agency awarded a $3,350.95 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used to treat cardiac arrhythmias. This competitive, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order utilizes firm fixed pricing and represents a child contract under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price delivery order, valued at $6,234.74, was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The award utilized no set-aside provisions and was competitively awarded to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,134.56 for 60-tablet units of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. This competitively awarded, firm fixed-price delivery order was established on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation,...
- The Defense Logistics Agency awarded a $2,624.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, which carries no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC56RDelivery Order
The Defense Logistics Agency awarded a $5,713.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitive award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 7/25/25 |